Gaudium IVF and Women Health
NSE: GAUDIUMIVF · ISIN INE0P8B01020 · Healthcare
₹105.75−1.00 (−0.94%)
Monday 9 November, 12:17 IST. Delayed. Source: Yahoo Finance.
Price chart
₹105.75 −1.00 (−0.94%) today
The day
- Previous close
- ₹106.75
- Open
- ₹108.34
- Day high
- ₹108.94
- Day low
- ₹105.43
Listed on NSE since 27 February 2026.
Key numbers
- Market value
- ₹769.72 Cr
- P/E (trailing)
- 31.29
- EPS (trailing)
- ₹3.38
- Price to book
- 4.33
- Dividend yield
- 0.00%
- Debt to equity
- 0.16
- Profit margin
- 21.9%
- Volume today
- 35,036
- Average volume
- 2.16 L
Source: Yahoo Finance. Ratios use the latest reported (trailing twelve-month) figures.
Revenue and profit
| Year | Revenue | Net profit |
|---|---|---|
| FY23 | ₹44.24 Cr | ₹13.53 Cr |
| FY24 | ₹47.89 Cr | ₹10.32 Cr |
| FY25 | ₹70.72 Cr | ₹19.17 Cr |
| FY26 | ₹104.36 Cr | ₹24.46 Cr |
Source: Yahoo Finance, from annual reports. Consolidated where reported.
Quarterly results
| Quarter | Revenue | Net profit | Profit vs year ago |
|---|---|---|---|
| Q1 FY27Apr–Jun 2026 | ₹19 Cr | ₹2 Cr | – |
| Q4 FY26Jan–Mar 2026Audited | ₹30 Cr | ₹8 Cr | – |
| Q3 FY26Oct–Dec 2025 | ₹25 Cr | ₹4 Cr | – |
Source: Gaudium IVF and Women Health’s results filed with NSE, consolidated (the whole group). Net profit is the share of Gaudium IVF and Women Health’s own shareholders where the filing separates it. Profit vs year ago compares with the same quarter a year earlier; – where that quarter is not on file or made a loss.
Download results (zip) A spreadsheet of the quarterly results and balance sheets, with the original filings from NSE.
Balance sheet
| As on | March 2026 |
|---|---|
| Fixed assets | ₹7 Cr |
| Investments | ₹5 Cr |
| Inventories | ₹4 Cr |
| Owed by customers | ₹53 Cr |
| Cash and equivalents | ₹9 Cr |
| Total assets | ₹193 Cr |
| Borrowings | ₹23 Cr |
| Total liabilities | ₹41 Cr |
| Shareholders’ equity | ₹152 Cr |
Source: Gaudium IVF and Women Health’s half-yearly statements of assets and liabilities filed with NSE, consolidated. Companies file these every September and March.
About Gaudium IVF and Women Health
Gaudium IVF and Women Health Limited provides in vitro fertilization (IVF) treatment in India. The company offers fertility and reproductive health services, including intracytoplasmic sperm injection (ICSI), intrauterine insemination (IUI), and ovulation induction; polycystic ovarian syndrome (PCOS)/ polycystic ovarian disease (PCOD); endometriosis treatment; ovulation induction; and laser assisted embryo implantation services. It also provides male infertility treatment services; egg freezing; embryo freezing; frozen embryo transfer; gynae consultation; laparoscopy for infertility; diagnostic services; and support and counselling services. In addition, the company operates hospital, in-house pharmacy; and 7 hubs (IVF centers) and 28 spokes. The company was founded in 2009 and is based in New Delhi, India.
- Industry
- Medical Care Facilities
- Based in
- New Delhi
- Employees
- 120
Company website · Profile: Yahoo Finance
In the news
All newsNo headlines name Gaudium IVF and Women Health in the last day or two.
Dividends and corporate actions
All companiesNSE lists no dividends or other corporate actions for Gaudium IVF and Women Health.
Information only, not investment advice. Prices are delayed.